Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: Emergence of Candida parapsilosis

Infection Control and Hospital Epidemiology

Volumn 26, Issue 6, 2005, Pages 548-552

  San Miguel, Lucía García ^a   Cobo, Javier ^a   Otheo, Enrique ^a   Sánchez Sousa, Aurora ^a   Abraira, Victor ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CULTURE; CANDIDA PARAPSILOSIS; DISEASE TRANSMISSION; FUNGUS ISOLATION; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; NONHUMAN; RETROSPECTIVE STUDY; SPAIN; TEACHING HOSPITAL;

CANDIDA; CANDIDIASIS; CLUSTER ANALYSIS; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; FUNGEMIA; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS, PEDIATRIC; MYCOLOGICAL TYPING TECHNIQUES; PATIENT ADMISSION; POPULATION SURVEILLANCE; RISK FACTORS; SPAIN;

EID: 21244500219     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502582     Document Type: Article

References (64)

1. Henderson VJ, Hirvela ER. Emerging and reemerging microbial threats: nosocomial fungal infections. Arch Surg 1996;3:330-337.
2. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
3. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987;147:2117-2120.
4. Beck Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990: National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167:1247-1251.
5. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-1530.
6. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177-1184.
7. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-81. Am J Med 1991;9(suppl 3B):3S-87S.
8. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998;31:327-332.
9. Poikonen E, Lyytikainen O, Anttila VJ, Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis 2003;9:985-990.
10. Hsueh PR, Teng LJ, Yang PC, Ho SW, Luh KT. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb Drug Resist 2002;8:311-319.
11. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-655.
12. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-390.
13. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-421.
14. Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM. Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn Microbiol Infect Dis 1997;29:5-9.
15. Voss A, le Noble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997;25:8-11.
16. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-1534.
17. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-508.
18. Baran J Jr, Muckatira B, Khatib R. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand J Infect Dis 2001;33:137-139.
19. Pfaller M. Nosocomial candidiasis: emerging species, reservoirs and models of transmission. Clin Infect Dis 1996;2:S89-S94.
20. Wright WL, Wenzel RP. Nosocomial Candida: epidemiology, transmission, and prevention. Infect Dis Clin North Am 1997;11:411-425.
21. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1997;20:115-125.
22. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998;30:121-129.
23. Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000;44:747-751.
24. Pfaller MA, Jones RN, Doern GV, et al. International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn Microbiol Infect Dis 1999;35:19-25.
25. Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003;123:5008-5035.
26. Peman J, Canton E, Orero A, Viudes A, Frasquet J, Gobernado M. Epidemiology of candidemia in Spain: multicenter study. Revista Ibero Americana de Micología 2002;19:30-35.
27. Safdar A, Perlin DS, Armstrong D. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades. Diagn Microbiol Infect Dis 2002;44:11-16.
28. Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999;34:213-220.
29. Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogenic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000;181:309-316.
30. Sherertz RJ, Gledhill KS, Hampton KD, et al. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. J Pediatr 1992;120:455-461.
31. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit. Diagn Microbiol Infect Dis 1995;21:191-194.
32. White GC, Sisson PR, Freeman R, Cookson BD. Rapid characterization of Candida albicans by pyrolysis mass spectrometry. J Med Microbiol 1994;41:98-105.
33. Vazquez JA, Sanchez V, Dmuchowski C, Dembry L, Jack D, Zervos MJ. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993;168:195-201.
34. Trilla A. Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Med 1994;20(suppl 3):S1-S4.
35. Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH. Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989;27:2426-2428.
36. Moro ML, Maffei C, Manso E, Morace G, Polonelli L, Biavasco F. Nosocomial outbreak of systemic candidosis associated with parenteral nutrition. Infect Control Hosp Epidemiol 1990;11:27-35.
37. Finkelstein R, Reinhertz G, Hashman N, Merzbach D. Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1993;14:587-590.
38. Betremieux P, Chevrier S, Quindos G, Sullivan D, Polonelli L, Guiguen C. Use of DNA fingerprinting and biotyping methods to study a Candida albicans outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 1994;13:899-905.
39. Welbel SF, McNeil MM, Kuykendall RJ, et al. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak. Pediatr Infect Dis J 1996;15:998-1002.
40. Levin AS, Costa SF, Mussi NS, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis 1998;30:243-249.
41. Huang YC, Lin TY, Peng HL, Wu JH, Chang HY, Leu HS. Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis 1998;30:137-142.
42. Lupetti A, Tavanti A, Davini P, et al. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 2002;40:2363-2369.
43. Bart Delabesse E, van Deventer H, Goessens W, et al. Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit. J Clin Microbiol 1995;33:3278-3283.
44. Noskin GA, Lee J, Hacek DM, et al. Molecular typing for investigating an outbreak of Candida krusei. Diagn Microbiol Infect Dis 1996;26:117-123.
45. Vazquez JA, Boikov D, Boikov S, Dajani AS. Use of electrophoretic karyotyping in the evaluation of Candida infections in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1997;18:32-37.
46. Diekema DJ, Messer SA, Hollis RJ, Wenzel RP, Pfaller MA. An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn Microbiol Infect Dis 1997;29:147-153.
47. Fowler SL, Rhoton B, Springer SC, Messer SA, Hollis RJ, Pfaller MA. Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998;19:343-345.
48. Pfaller MA, Messer SA, Houston A, et al. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998;31:289-296.
49. Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection 1999;27:97-102.
50. Shin JH, Kook H, Shin DH, et al. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur J Clin Microbiol Infect Dis 2000;19:344-349.
51. Rodero L, Hochenfellner F, Demkura H, et al. Nosocomial transmission of Candida albicans in newborn infants. Rev Argent Microbiol 2000;32:179-184.
52. Baran J Jr, Muckatira B, Khatib R. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand J Infect Dis 2001;33:137-139.
53. Rennert G, Rennert HS, Pitlik S, Finkelstein R, Kitzes-Cohen R. Epidemiology of candidemia: a nationwide survey in Israel. Infection 2000;28:26-29.
54. Abraira V, Pérez de Vargas A. Multivariate Methods in Biostatistics. Madrid: Editorial Centro de Estudios Ramón Areces; 1996.
55. Roilides E, Kadiltsoglou I, Zahides D, Bibashi E. Invasive candidosis in pediatric patients. Clin Microbiol Infect 1997;3:192-197.
56. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients: the National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000;19:319-324.
57. Nucci M, Silveira MI, Spector N, et al. Fungemia in cancer patients in Brazil: predominance of non-albicans species. Mycopathologia 1998;141:65-68.
58. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998;26:1086-1088.
59. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995;20:571-575.
60. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1997;26:642-645.
61. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992;14:756-766.
62. Saxen H, Virtanen M, Carlson P, et al. Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J 1995;14:776-781.
63. Pfaller MA. Epidemiology of candidiasis. J Hosp Infect 1995;30(suppl):329-338.
64. Pfaller MA, Messer SA, Hollis RJ. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn Microbiol Infect Dis 1995;21:9-14.